StonvexLoading…
StonvexCore line items from SHW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $23.57B | $23.10B | $23.05B | $22.15B |
Operating Income | $3.34B | $3.45B | $4.16B | $3.40B |
Net Income | $2.57B | $2.68B | $2.39B | $2.02B |
EPS (Diluted) | $10.26 | $10.55 | $9.25 | $7.72 |
Total Assets | $25.90B | $23.63B | $22.95B | $22.59B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $207.20M | $210.40M | $276.80M | $198.80M |
Free Cash Flow OCF − CapEx | $2.65B | $2.08B | $2.63B | $1.28B |
Shares Outstanding | 247.70M | 251.30M | 254.50M | 258.90M |